Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvano Adami

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronateJean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, et al.
Clinical and Experimental Rheumatology|July 7, 2015
Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and CanadaAnkita Modi, Shuvayu Sen, Jonathan D Adachi, et al.
Calcified Tissue International|December 11, 2008
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of boneAlberto Falchetti, Marco Di Stefano, Francesca Marini, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosisSteven R Cummings, Javier San Martin, Michael R McClung, et al.
Arthritis and Rheumatism|May 27, 2006
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration studyPierre D Delmas, Silvano Adami, Cezary Strugala, et al.
Arthritis and Rheumatism|November 1, 2006
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis studyClifton O Bingham, J Chris Buckland-Wright, Patrick Garnero, et al.
Clinical Rheumatology|August 20, 2013
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics registerFlorenzo Iannone, Elisa Gremese, Gaia Gallo, et al.
The Journal of Bone and Joint Surgery. American Volume|October 26, 2012
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trialSilvano Adami, Cesar Libanati, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2011
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fracturesMatthew Austin, Yu-Ching Yang, Eric Vittinghoff, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2005
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronateJean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, et al.
Clinical and Experimental Rheumatology|July 7, 2015
Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and CanadaAnkita Modi, Shuvayu Sen, Jonathan D Adachi, et al.
Calcified Tissue International|December 11, 2008
Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of boneAlberto Falchetti, Marco Di Stefano, Francesca Marini, et al.
The New England Journal of Medicine|August 13, 2009
Denosumab for prevention of fractures in postmenopausal women with osteoporosisSteven R Cummings, Javier San Martin, Michael R McClung, et al.
Arthritis and Rheumatism|May 27, 2006
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration studyPierre D Delmas, Silvano Adami, Cezary Strugala, et al.
Arthritis and Rheumatism|November 1, 2006
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis studyClifton O Bingham, J Chris Buckland-Wright, Patrick Garnero, et al.
Clinical Rheumatology|August 20, 2013
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics registerFlorenzo Iannone, Elisa Gremese, Gaia Gallo, et al.
The Journal of Bone and Joint Surgery. American Volume|October 26, 2012
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trialSilvano Adami, Cesar Libanati, Steven Boonen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 19, 2011
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fracturesMatthew Austin, Yu-Ching Yang, Eric Vittinghoff, et al.
Lancet (London, England)|August 10, 2013
Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trialNick Bishop, Silvano Adami, S Faisal Ahmed, et al.
Pageof 13